| |
| |
|
| Insider
Information: |
Clayman Michael D. |
| Relationship: |
President and CEO, Dir... |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Flexion Therapeutics Inc |
FLXN |
President and CEO, Dir... |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-11-19 |
4 |
D |
$8.50 |
$6,689,942 |
I/I |
(787,052) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-11-19 |
4 |
D |
$8.50 |
$2,851,733 |
D/D |
(335,498) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-06-21 |
4 |
A |
$7.78 |
$13,226 |
D/D |
1,700 |
348,840 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
106,100 |
373,001 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,099 |
347,140 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-01-28 |
4 |
D |
$12.37 |
$108,559 |
D/D |
(8,776) |
266,901 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
119,500 |
275,677 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,762 |
368,239 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2021-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,530) |
156,177 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
93,750 |
160,010 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-07-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,303 |
158,707 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-06-22 |
4 |
A |
$10.83 |
$14,111 |
D/D |
1,303 |
66,260 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-05-26 |
4 |
B |
$9.75 |
$99,996 |
I/I |
10,256 |
346,605 |
2.66 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-01-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,457 |
336,349 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-01-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,457 |
64,957 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2020-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,494) |
70,414 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-10-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,398 |
330,892 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-10-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,398 |
72,249 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-10-07 |
4 |
D |
$13.98 |
$61,540 |
D/D |
(4,402) |
82,647 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,800 |
87,049 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-08-08 |
4 |
B |
$10.85 |
$25,136 |
D/D |
2,317 |
72,249 |
2.81 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-06-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,492 |
69,932 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-06-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,492 |
320,494 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-06-21 |
4 |
A |
$9.81 |
$14,637 |
D/D |
1,492 |
71,424 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
President and CEO |
• • – |
2019-05-10 |
4 |
B |
$12.48 |
$50,067 |
D/D |
4,012 |
74,868 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
